Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “THE UNITED STATES OF AMERICA, as represented by th”

2,147 pharma patents match "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,147
Index total 30,257
Page 30 / 90

Quick answer

This filtered view shows 2,147 pharmaceutical patents matching "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,147 results for “THE UNITED STATES OF AMERICA, as represented by th” · 30,257 patents in full index Clear search

  1. US 10086061

    Combination purified inactivated vaccine for flaviviruses

    The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  2. US 10087148

    Quinazolines as biogenic amine transport modulators

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  3. US 10087211

    Androstane and pregnane steroids with potent allosteric gaba receptor chloride ionophore modulating properties

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  4. US 10077296

    Methods and compositions for the treatment and prevention of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted

  5. US 10076535

    Use of CPG oligonucleotides co-formulated with an antibiotic to accelerate wound healing

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted

  6. US 10072070

    Potent anti-influenza A neuraminidase subtype N1 antibody

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted

  7. US 10071945

    Nuclear receptor modulators and their use for the treatment and prevention of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted

  8. US 10072078

    M971 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted

  9. US 10058602

    Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  10. US 10058559

    Treatment or prevention of an intestinal disease or disorder

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  11. US 10052369

    Aquaporin 2 protects cattle from ticks and tick-borne parasites

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

  12. US 10053503

    Monoclonal antibodies that neutralize anthrax toxins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

  13. US 10051880

    Hydroxybutyrate ester and medical use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

  14. US 10047401

    Expression protein-coding and noncoding genes as prognostic classifiers in early stage lung cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  15. US 10047147

    Neutralizing GP41 antibodies and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  16. US 10047148

    Neutralizing GP41 antibodies and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  17. US 10046012

    Multipotent postnatal stem cells from human periodontal ligament and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  18. US 10047122

    Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  19. US 10039819

    Attenuated Mannheimia haemolytica strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted

  20. US 10039818

    Attenuated pasteurella multocida strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted

  21. US 10035848

    Antibody targeting cell surface deposited complement protein C3d and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  22. US 10036020

    Compositions and methods for inhibiting JC virus (JCV)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  23. US 10035845

    Neutralizing antibodies to HIV-1 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  24. US 10035833

    Vascular endothelial growth factor antagonists and methods of making

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.